Erasca (ERAS) Financials: Revenue & Earnings
ERAS$15.15-0.07 -0.46%
$5.30B
Market Cap
-15.78
P/E
—
Forward P/E
67
Score
Erasca (ERAS) Financials: Revenue & Earnings
ERAS price $15.15 -0.07 -0.46%
- Ticker
- ERAS
- Price
- $15.15
- Change
- -0.07 -0.46%
- Market cap ?
- $5.30B
- P/E ?
- -15.78
- Dividend yield ?
- 0.00%
- Beta ?
- 0.62
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 67
- Value
- 58
- Quality
- 46
- Growth
- 97
Stocklytics score rationale: value 58, quality 46, growth 97.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on identifying, advancing, and commercializing therapeutic solutions for malignancies propelled by the RAS/MAPK pathway. The firm's pipeline features several key experimental drugs: ERAS-007, an orally administered ERK1/2 inhibitor designed to address non-small cell lung cancer, colorectal cancer, and acute myeloid…
Fair value
ERAS fair value Not meaningful. Price $15.15.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.13 | — | — |
| 2026-08-12 | -0.14 | -0.11 | — | — |
| 2026-05-11 | -0.60 | -0.11 | — | — |
| 2026-03-12 | -0.10 | -0.11 | — | — |
| 2025-11-12 | -0.11 | -0.11 | — | — |
| 2025-08-12 | -0.12 | -0.12 | — | — |
| 2025-05-13 | -0.11 | -0.12 | — | — |
| 2025-03-20 | -0.11 | -0.12 | — | — |
| 2024-11-12 | -0.11 | -0.17 | — | — |
| 2024-08-12 | -0.29 | -0.17 | — | — |
| 2024-05-08 | -0.23 | -0.21 | — | — |
| 2024-03-27 | -0.20 | -0.24 | 5.58M | — |
| 2023-11-09 | -0.20 | -0.21 | — | — |
| 2023-08-10 | -0.21 | -0.27 | — | — |
| 2023-05-15 | -0.22 | -0.30 | — | — |
| 2023-03-23 | -0.28 | -0.30 | — | — |
| 2022-11-09 | -0.29 | -0.31 | — | — |
| 2022-08-11 | -0.30 | -0.33 | — | — |
| 2022-05-12 | -0.31 | -0.30 | — | — |
| 2022-03-24 | -0.26 | -0.31 | — | — |
| 2021-11-10 | -0.27 | -0.32 | — | — |
| 2021-08-26 | -1.20 | -0.65 | — | — |
| 2021-07-16 | -0.10 | — | — | — |
| 2020-12-31 | -0.34 | — | — | — |
| 2020-09-30 | -0.06 | — | — | — |
| 2020-06-30 | -0.03 | — | — | — |
| 2020-03-31 | -0.03 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Fuchs Charles S. | Buy | 1.30M | $18.12 | 23.56M |
| 2026-08-10 | Fuchs Charles S. | Other | 0 | — | — |
| 2026-06-26 | Start Valerie Denise Harding | Buy | 29.89K | $16.01 | 478.51K |
| 2026-06-26 | LIU JEAN I | Buy | 29.89K | $16.01 | 478.51K |
| 2026-06-26 | Multani Pratik S | Buy | 29.89K | $16.01 | 478.51K |
| 2026-06-26 | Casdin Alexander W. | Buy | 29.89K | $16.01 | 478.51K |
| 2026-06-26 | Hambleton Julie | Buy | 29.89K | $16.01 | 478.51K |
| 2026-06-26 | Bristol James Arthur | Buy | 29.89K | $16.01 | 478.51K |
| 2026-04-01 | Garner Ebun | Sell | 80.00K | $1.70 | 136.00K |
| 2026-04-01 | Garner Ebun | Buy | 80.00K | $1.70 | 136.00K |
| 2026-04-01 | Garner Ebun | Sell | 80.00K | $16.40 | 1.31M |
| 2026-03-04 | Morris Shannon | Buy | 20.00K | $1.70 | 34.00K |
| 2026-03-04 | Morris Shannon | Sell | 20.00K | $15.04 | 300.76K |
| 2026-01-29 | Lim Jonathan E | Buy | 2.00M | $10.31 | 20.62M |
| 2026-01-29 | Chacko David M. | Buy | 640.00K | $10.31 | 6.60M |
| 2026-01-29 | Morris Shannon | Buy | 625.00K | $10.31 | 6.44M |
| 2026-01-29 | Varney Michael David | Buy | 96.00K | $10.31 | 989.76K |
| 2026-01-29 | Garner Ebun | Buy | 560.00K | $10.31 | 5.77M |
| 2026-01-07 | Garner Ebun | Buy | 120.00K | $1.70 | 204.00K |
| 2026-01-07 | Garner Ebun | Sell | 120.00K | $5.59 | 670.81K |
| 2026-01-01 | Bristol James Arthur | Buy | 37.76K | $3.72 | 140.47K |
| 2026-01-01 | LIU JEAN I | Buy | 20.62K | $3.72 | 76.70K |
| 2026-01-01 | Multani Pratik S | Buy | 19.53K | $3.72 | 72.66K |
| 2026-01-01 | Start Valerie Denise Harding | Buy | 24.31K | $3.72 | 90.42K |
| 2026-01-01 | Casdin Alexander W. | Buy | 23.87K | $3.72 | 88.80K |
| 2025-12-15 | Chacko David M. | Buy | 17.79K | $1.19 | 21.25K |
| 2025-12-15 | Garner Ebun | Buy | 3.90K | $1.19 | 4.66K |
| 2025-06-24 | Varney Michael David | Buy | 120.00K | $1.45 | 174.00K |
| 2025-06-24 | LIU JEAN I | Buy | 120.00K | $1.45 | 174.00K |
| 2025-06-24 | Hambleton Julie | Buy | 120.00K | $1.45 | 174.00K |
| 2025-06-24 | Start Valerie Denise Harding | Buy | 120.00K | $1.45 | 174.00K |
| 2025-06-24 | Multani Pratik S | Buy | 120.00K | $1.45 | 174.00K |
| 2025-06-24 | Bristol James Arthur | Buy | 120.00K | $1.45 | 174.00K |
| 2025-06-24 | Casdin Alexander W. | Buy | 120.00K | $1.45 | 174.00K |
| 2025-05-23 | Multani Pratik S | Sell | 6.20K | — | — |
| 2025-05-23 | Multani Pratik S | Buy | 6.20K | — | — |
| 2025-03-04 | Morris Shannon | Sell | 20.00K | $1.70 | 34.00K |
| 2025-02-13 | Garner Ebun | Buy | 50.00K | $1.63 | 81.50K |
| 2025-02-03 | Chacko David M. | Buy | 800.00K | $1.76 | 1.41M |
| 2025-02-03 | Morris Shannon | Buy | 780.00K | $1.76 | 1.37M |
| 2025-02-03 | Garner Ebun | Buy | 700.00K | $1.76 | 1.23M |
| 2025-02-03 | Lim Jonathan E | Buy | 2.50M | $1.76 | 4.40M |
| 2025-01-07 | Garner Ebun | Sell | 120.00K | $1.70 | 204.00K |
| 2025-01-01 | Casdin Alexander W. | Buy | 28.88K | $2.51 | 72.48K |
| 2025-01-01 | LIU JEAN I | Buy | 24.94K | $2.51 | 62.60K |
| 2025-01-01 | Start Valerie Denise Harding | Buy | 29.40K | $2.51 | 73.80K |
| 2025-01-01 | Bristol James Arthur | Buy | 45.68K | $2.51 | 114.65K |
| 2024-12-13 | Chacko David M. | Buy | 12.32K | $1.56 | 19.27K |
| 2024-12-13 | Garner Ebun | Buy | 5.73K | $1.56 | 8.96K |
| 2024-06-20 | Varney Michael David | Buy | 60.00K | $2.03 | 121.80K |
| 2024-06-20 | Start Valerie Denise Harding | Buy | 60.00K | $2.03 | 121.80K |
| 2024-06-20 | LIU JEAN I | Buy | 60.00K | $2.03 | 121.80K |
| 2024-06-20 | Garner Ebun | Buy | 160.08K | $2.03 | 324.97K |
| 2024-06-20 | Morris Shannon | Buy | 137.14K | $2.03 | 278.40K |
| 2024-06-20 | Lim Jonathan E | Buy | 632.76K | $2.03 | 1.28M |
| 2024-06-20 | Chacko David M. | Buy | 278.81K | $2.03 | 565.99K |
| 2024-06-20 | Hambleton Julie | Buy | 60.00K | $2.03 | 121.80K |
| 2024-06-20 | Casdin Alexander W. | Buy | 60.00K | $2.03 | 121.80K |
| 2024-06-20 | Bristol James Arthur | Buy | 60.00K | $2.03 | 121.80K |
| 2024-06-20 | Multani Pratik S | Buy | 60.00K | $2.03 | 121.80K |
| 2024-05-21 | Casdin Alexander W. | Buy | 80.00K | $2.27 | 181.92K |
| 2024-02-05 | Lim Jonathan E | Buy | 1.50M | $1.70 | 2.55M |
| 2024-02-05 | Chacko David M. | Buy | 600.00K | $1.70 | 1.02M |
| 2024-02-05 | Garner Ebun | Buy | 480.00K | $1.70 | 816.00K |
| 2024-02-05 | Morris Shannon | Buy | 535.80K | $1.70 | 910.86K |
| 2024-01-01 | Bristol James Arthur | Buy | 62.75K | $2.13 | 133.65K |
| 2024-01-01 | Multani Pratik S | Buy | 32.87K | $2.13 | 70.01K |
| 2024-01-01 | LIU JEAN I | Buy | 35.48K | $2.13 | 75.58K |
| 2024-01-01 | Start Valerie Denise Harding | Buy | 39.59K | $2.13 | 84.33K |
| 2024-01-01 | Casdin Alexander W. | Buy | 41.08K | $2.13 | 87.51K |
| 2023-12-15 | Chacko David M. | Buy | 7.48K | $1.59 | 11.89K |
| 2023-12-15 | Garner Ebun | Buy | 5.45K | $1.59 | 8.66K |
| 2023-12-06 | Start Valerie Denise Harding | Buy | 10.00K | $1.85 | 18.48K |
| 2023-12-06 | Lim Jonathan E | Buy | 278.15K | $1.72 | 478.42K |
| 2023-12-05 | Lim Jonathan E | Buy | 721.85K | $1.69 | 1.22M |
| 2023-12-04 | Casdin Alexander W. | Buy | 30.00K | $1.66 | 49.78K |
| 2023-10-05 | Lim Jonathan E | Buy | 1.00M | $2.03 | 2.03M |
| 2023-06-22 | Chen Bihua | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | Varney Michael David | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | Multani Pratik S | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | LIU JEAN I | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | Start Valerie Denise Harding | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | Hambleton Julie | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | Casdin Alexander W. | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-22 | Bristol James Arthur | Buy | 60.00K | $2.66 | 159.60K |
| 2023-06-08 | Lim Jonathan E | Buy | 100.00K | $2.75 | 275.00K |
| 2023-04-10 | Morris Shannon | Buy | 375.00K | $2.73 | 1.03M |
| 2023-04-10 | Morris Shannon | Sell | 300.00K | $7.91 | 2.37M |
| 2023-04-10 | Morris Shannon | Sell | 160.80K | $4.00 | 643.20K |
| 2023-04-10 | Casdin Alexander W. | Buy | 20.00K | $2.76 | 55.23K |
| 2023-03-28 | Lim Jonathan E | Other | 0 | — | — |
| 2023-03-28 | Lim Jonathan E | Buy | 100.00K | $2.84 | 284.00K |
| 2023-02-01 | Lim Jonathan E | Buy | 1.50M | $4.00 | 6.00M |
| 2023-02-01 | Chacko David M. | Buy | 600.00K | $4.00 | 2.40M |
| 2023-02-01 | Chacko David M. | Buy | 1.75K | $4.10 | 7.16K |
| 2023-02-01 | Chacko David M. | Buy | 2 | $3.89 | 8 |
| 2023-02-01 | Wei Lin | Buy | 560.00K | $4.00 | 2.24M |
| 2023-02-01 | Wei Lin | Buy | 1.75K | $4.10 | 7.16K |
| 2023-02-01 | Wei Lin | Buy | 2 | $3.89 | 8 |
| 2023-02-01 | Garner Ebun | Buy | 480.00K | $4.00 | 1.92M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 274, holders +40 vs prior quarter. Ownership 90.68%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 24.98M | 300.00K | +1.22% | 457.55M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 21.19M | -73.81K | -0.35% | 388.12M |
| BLACKROCK, INC. | 21.15M | 1.00M | +4.98% | 387.54M |
| RTW INVESTMENTS, LP | 17.95M | 1.79M | +11.08% | 328.78M |
| VENROCK ADVISER, LLC | 17.89M | 1.51M | +9.21% | 327.78M |
| STATE STREET CORP | 12.18M | 2.88M | +31.02% | 223.22M |
| LOGOS GLOBAL MANAGEMENT LP | 12.15M | 1.00M | +8.97% | 222.59M |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.40M | 152.46K | +1.36% | 208.89M |
| SIREN, L.L.C. | 11.40M | 153.53K | +1.37% | 208.81M |
| PARADIGM BIOCAPITAL ADVISORS LP | 9.55M | -842.70K | -8.11% | 174.96M |
| ARCH VENTURE MANAGEMENT, LLC | 7.09M | 0 | 0.00% | 129.92M |
| GEODE CAPITAL MANAGEMENT, LLC | 6.50M | 505.28K | +8.43% | 119.13M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.27M | 4.46M | +245.53% | 114.91M |
| CORMORANT ASSET MANAGEMENT, LP | 6.00M | 200.00K | +3.45% | 109.92M |
| AFFINITY ASSET ADVISORS, LLC | 5.25M | -100.00K | -1.87% | 96.18M |
| VIVO CAPITAL, LLC | 4.13M | -8.02M | -66.03% | 75.61M |
| GOLDMAN SACHS GROUP INC | 3.82M | -1.05M | -21.60% | 70.02M |
| CAPTION MANAGEMENT, LLC | 3.74M | 3.24M | +648.20% | 68.54M |
| ALLIANCEBERNSTEIN L.P. | 4.12M | 1.47M | +55.72% | 66.64M |
| BANK OF AMERICA CORP /DE/ | 3.05M | -7.16K | -0.23% | 55.85M |
| FMR LLC | 2.88M | 1.39M | +93.51% | 52.82M |
| A16Z CAPITAL MANAGEMENT, L.L.C. | 2.86M | 0 | 0.00% | 52.44M |
| WOODLINE PARTNERS LP | 2.83M | 329 | +0.01% | 51.88M |
| JENNISON ASSOCIATES LLC | 2.79M | 2.79M | New | 51.08M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.70M | 2.70M | New | 49.46M |
Earnings and financials
Erasca, Inc. (ERAS) trades at $15.15, with a market cap of $5.30B and a trailing P/E of -15.78. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insights · Dividends · Forecast · Financials · Learn